This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Baylor College of Medicine, Beijing University of Technology, La Trobe University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 619 
1 out of 389 
1 out of 22 
Years Active: 2019
Title: Shih Chieh Chang: Innovator in Autoimmune Disease Treatment
Introduction
Shih Chieh Chang is a prominent inventor based in Singapore, known for her groundbreaking work in the field of autoimmune disease treatment. With a focus on potassium channel blockers, her research has the potential to significantly impact therapeutic approaches for various autoimmune conditions.
Latest Patents
Chang holds a patent for "Potassium channel blockers and use thereof in the treatment of autoimmune diseases." This patent discloses novel analogues of the sea anemone toxin ShK, which serve as therapeutic agents for treating autoimmune diseases. The analogues consist of a ShK toxin polypeptide and an N-terminal extension with a specific amino acid sequence, providing innovative solutions for medical treatment.
Career Highlights
Throughout her career, Shih Chieh Chang has made significant contributions to the scientific community. She has worked at esteemed institutions such as La Trobe University and Beijing University of Technology, where she has furthered her research and development in the field of biomedicine.
Collaborations
Chang has collaborated with notable professionals in her field, including Raymond S. Norton and Michael W. Pennington. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Shih Chieh Chang's contributions to the field of autoimmune disease treatment through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic solutions for autoimmune conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile